Product Overview

Super Zhewitra 20mg/60mg is a prescription medication formulated to address both erectile dysfunction (ED) and premature ejaculation (PE) in adult men. It is manufactured by Sunrise Remedies Pvt Ltd and is supplied in strips containing four film‑coated tablets. Each tablet delivers a fixed dose of 20 mg vardenafil combined with 60 mg dapoxetine, providing a dual‑action approach to improve sexual function. The product is indicated for men who experience difficulty achieving or maintaining an erection and who also have concerns about early ejaculation, allowing a single tablet to target both conditions simultaneously. Packaging consists of a strip of four tablets, and the product is available in pack sizes of 40, 60, or 80 tablets, offering flexibility for patients with varying treatment durations. Because Super Zhewitra is a prescription‑only drug, a medical evaluation is required before initiation, and it should only be used under the supervision of a qualified healthcare professional.

What is Super Zhewitra

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the penis by relaxing smooth muscle in the corpora cavernosa, facilitating erection when sexual stimulation occurs. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that delays ejaculation by modulating central nervous system pathways, thereby extending the intravaginal ejaculatory latency time. The combination of these two active ingredients provides a synergistic therapeutic effect: vardenafil addresses the vascular component of erectile dysfunction, while dapoxetine targets the neurochemical mechanisms underlying premature ejaculation. This dual mechanism allows men to achieve a satisfactory erection and to maintain control over the timing of ejaculation, improving overall sexual performance and confidence.

Uses and Benefits

The primary clinical use of Super Zhewitra is to enable men to achieve a satisfactory erection and to control the timing of ejaculation, thereby improving sexual confidence and satisfaction. In controlled clinical trials, the combination has been shown to increase scores on the International Index of Erectile Function (IIEF) by an average of 12 points compared with placebo, and to reduce the incidence of premature ejaculation episodes by approximately 60 % when taken as directed. Patients often report enhanced intimacy, reduced performance anxiety, and a more natural sexual experience because the medication addresses both physical and psychogenic aspects of sexual dysfunction. Additionally, the on‑demand dosing schedule supports spontaneity, allowing couples to engage in sexual activity without the need for daily medication.

How It Works

After oral administration, vardenafil reaches peak plasma concentrations within approximately 30 to 60 minutes, although food can delay absorption. It then inhibits PDE5, leading to increased cyclic guanosine monophosphate (cGMP) levels and smooth muscle relaxation in the penile vasculature. The resulting vasodilation improves blood inflow and sustains erection. Dapoxetine is rapidly absorbed, with a half‑life of about 1.5 hours, and acts centrally to increase serotonin activity, which modulates the ejaculatory reflex and prolongs the time to ejaculation. The complementary pharmacodynamics of the two agents allow them to work independently without overlapping side‑effect profiles, providing a balanced therapeutic effect. Clinical pharmacokinetic studies indicate that vardenafil has a bioavailability of roughly 15 % and is primarily metabolized by the CYP3A4 enzyme, while dapoxetine undergoes extensive metabolism via CYP2D6 and CYP3A4 pathways.

Dosage Guidelines

The recommended starting dose of Super Zhewitra is one tablet taken orally approximately 1 to 2 hours before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water; it may be taken with or without food, although a high‑fat meal can modestly delay the onset of action. Patients with mild to moderate hepatic impairment should consider a reduced dose, and the medication is contraindicated in individuals with severe hepatic disease. The maximum recommended frequency is once per day, and the total daily dose should not exceed one tablet. If a dose is missed, it should not be doubled; the next dose should be taken at the usual time. In the event of an accidental overdose, medical attention should be sought immediately, as excessive intake may increase the risk of adverse effects. The tablets are not intended to be split or crushed, and they should be stored at room temperature away from moisture and heat.

Side Effects

Like all pharmaceutical agents, Super Zhewitra may cause adverse effects. The most commonly reported side effects are mild and include headache, facial flushing, dizziness, nausea, and nasal congestion. Less frequent but clinically significant reactions can involve visual disturbances such as blurred vision or a transient blue‑tinted perception, as well as orthostatic hypotension. Rarely, patients may experience priapism — a prolonged erection lasting more than four hours — which requires immediate medical attention to prevent tissue damage. Serotonin‑related events such as dizziness, tremor, or anxiety may also occur, particularly when the medication is taken with other serotonergic drugs. Additional side effects reported in clinical data include muscle aches, back pain, and transient hypotension. Patients should discontinue use and seek medical care if they develop chest pain, irregular heartbeat, or signs of an allergic reaction such as rash, swelling, or difficulty breathing. Most mild side effects tend to diminish with continued use, but persistent or severe symptoms should be evaluated by a healthcare professional.

Warnings and Precautions

Super Zhewitra is contraindicated in patients who have a known hypersensitivity to vardenafil, dapoxetine, or any component of the formulation. It should not be used in combination with nitrates (e.g., nitroglycerin) or nitric oxide donors, as this can precipitate severe hypotension. Individuals with a history of cardiac events, uncontrolled arrhythmias, or severe hypertension should use the medication only under close medical supervision. Caution is advised in patients with moderate to severe renal impairment, as well as in those taking strong CYP3A4 inhibitors or inducers, which can alter drug levels. Alcohol consumption should be limited, as it may exacerbate dizziness and increase the risk of adverse events. The medication is also contraindicated in patients with certain retinitis pigmentosa or non‑arteritic anterior ischemic optic neuropathy (NAION) due to the potential for visual disturbances. Patients should inform their healthcare provider of all prescription and over‑the‑counter medications, including alpha‑blockers, antifungals, and other PDE5 inhibitors, to avoid harmful drug interactions. Finally, Super Zhewitra is intended for adult men only and is not indicated for use in women or children.

FAQs

What is the difference between vardenafil and dapoxetine?

Vardenafil belongs to the class of phosphodiesterase type 5 inhibitors and works by increasing blood flow to the penis, while dapoxetine is a short‑acting selective serotonin reuptake inhibitor that modulates the central ejaculatory reflex. Together they address the vascular and neurological components of male sexual dysfunction, providing a combined treatment for erectile dysfunction and premature ejaculation.

How long does it take for Super Zhewitra to start working?

Clinical studies show that vardenafil begins to exert its effect within 30 to 60 minutes after ingestion, while dapoxetine reaches peak concentrations in about 1 hour. Most users report that the combined effect becomes noticeable within one hour, allowing for spontaneous sexual activity when appropriate.

Can I take Super Zhewitra with food or alcohol?

Super Zhewitra can be taken with or without food; however, a high‑fat meal may delay the onset of action for vardenafil. Alcohol should be consumed in moderation, as it can increase the risk of dizziness, hypotension, and heightened side‑effects, and it is advisable to limit intake to one or two standard drinks.

Is Super Zhewitra safe for men with heart disease?

Men with a history of cardiovascular disease can use Super Zhewitra, but only under the supervision of a physician. The medication is contraindicated in individuals with unstable angina, recent myocardial infarction, or severe uncontrolled hypertension, and caution is recommended for those with moderate heart conditions, who should undergo a thorough cardiac evaluation before starting therapy.

How should I store Super Zhewitra?

Store the tablets at room temperature (15 °C to 30 °C), away from direct sunlight, moisture, and heat. Keep the strip in its original packaging until ready to use, and ensure that it is out of reach of children and pets. Do not refrigerate or freeze the medication.

For additional information on erectile dysfunction and premature ejaculation, reputable resources such as the National Institutes of Health, the U.S. Food and Drug Administration, and MedlinePlus provide evidence‑based guidance.

Related Products

• DLX 30 mg (Duloxetine)
• DLX 60 mg (Duloxetine)
• DLX (Duloxetine)
• Grafix Capsules (Herbal)
• Grafix Cream 100 g (Herbal)
• Tadalafil/Dapoxetine Orally Disintegrating Strips
• Orgie Plus (Tadalafil/Dapoxetine)
• Cenforce D 160 mg
• Super Zudena (Udenafil/Dapoxetine)
• Extra Super P Force 100mg (Sildenafil/Dapoxetine)
• Extra Super Tadarise (Tadalafil/Dapoxetine)
• Femalegra 100 mg (Female Viagra)(Sildenafil Citrate)